ATNF Average Annual Return Since 2017

This page is part of our 2017 average annual return archive: it shows the ATNF Average Annual return Since for calendar year 2017. This metric helps investors evaluate and compare performance among different stocks, over time.

Average annual return should be reviewed alongside overall market trends, and company fundamentals like earnings and revenue. As the saying goes on Wall St., past performance from 2017 does not guarantee future similar returns.

ATNF Average Annual Return Since 2017
ATNF Average Annual Return Chart Since 2017
Growth of $10,000.00
Without Dividends Reinvested Into ATNF

Also see:
• ATNF stock yearly return 2018
• ATNF stock yearly return 2019
• ATNF stock yearly return 2020
• ATNF stock yearly return 2021
• ATNF stock yearly return 2022
• ATNF stock yearly return 2023
• ATNF stock yearly return 2024
• ATNF YTD return
Average Annual Return Benchmarks
Compare ATNF average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
ATNF Share Performance
ATNF Average Annual Return Table Since 2017
Start date: 06/28/2017
End date: 08/15/2025
Start price/share: $3,686.00
End price/share: $7.04
Dividends collected/share: $0.00
Total return: -99.81%
ATNF Average Annual Return: -53.67%
Starting investment: $10,000.00
Ending investment: $19.10
Years: 8.14


ATNF average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About ETHZilla Corp
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Co. is primary focused on program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). Co. has three product development platforms: Anti-TNF platform, SCAs platform and a7nAChR platform. Anti-TNF platform is focused on fibrosis and anti-tumor necrosis factor (anti-TNF). SCAs platform is focused on drugs which are synthetic cannabidiol (CBD) or cannabigerol (CBG) analogues (SCAs). a7nAChR platform is focused on alpha 7 nicotinic acetylcholine receptor (a7nAChR). The ATNF average annual return since 2017 is shown above.

The Average Annual Return on the ATNF average annual return since 2017 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether ATNF average annual return since 2017 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ATNF average annual return calculation with any dividends reinvested as applicable (on ex-dates).
ATNF Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree ATNF Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Average Annual Return Peers
ETHZilla (ATNF) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

ATOS Average Annual Return
ATRA Average Annual Return
ATRC Average Annual Return
ATXS Average Annual Return
ATYR Average Annual Return
AURA Average Annual Return
AVAH Average Annual Return
AVBP Average Annual Return
AVIR Average Annual Return
AVNS Average Annual Return
More Healthcare companies »

 

ATNF Average Annual Return Since 2017 | www.AverageAnnualReturn.com | Copyright © 2021 - 2025, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.